In December 2016 Harbour Antibodies was acquired by Harbour BioMed, a Shanghai-based company, to develop next-generation therapeutic antibodies for cancer.
Harbour BioMed Acquires Harbour Antibodies to Create Global, Oncology-focused Biotechnology Company
Harbour BioMed Acquires Harbour Antibodies to Create Global, Oncology-focused Biotechnology Company
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $3.31M
Founded date: 2006
Investors 1
| Date | Name | Website |
| - | Atlas Vent... | atlasventu... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.07.2013 | - | $3.31M | - |
Mentions in press and media 1
| Date | Title | Description |
| 25.07.2013 | Harbour Antibodies Raises €2.5M in Funding | Harbour Antibodies BV, a Rotterdam, The Netherlands, and Cambridge, MA-based creator of transgenic mice to aid in the discovery of new human antibody-based therapies, raised €2.5M ($3.3M) in funding. The round was led by Atlas Venture. In c... |